Indian Health Service adopts policy for prescription drug monitoring


A naloxone kit. Photo by Nabarun Dasgupta / Harm Reduction Coalition

The Indian Health Service has adopted a new policy aimed at curbing prescription opioid abuse.

Effective immediately, the IHS will be required to check state-run prescription drug monitoring programs before prescribing or dispensing any opioid for more than seven days.

"Checking a PDMP before prescribing helps to improve appropriate pain management care, identify patients who may have an opioid use disorder and prevent diversion of drugs," the White House announced on Wednesday.

Last December, the IHS and the Bureau of Indian Affairs started a partnership to equip police officers with naloxone kits. Naloxone can reverse the effects of overdoses from opiates like heroin and can prevent deaths.

Join the Conversation

Related Stories
Senate panel rejects marijuana amendment in tribal jurisdiction bill (06/22)
Bill John Baker: Cherokee Nation fights opioid abuse in Oklahoma (06/13)
Bill seeks random drug tests for Indian Health Service employees (6/10)
Gyasi Ross: Drug epidemic sweeping through Native communities (05/26)
Bill in Senate expands tribal jurisdiction over non-Indian offenders (04/14)
North American Inter-Tribal Drug Task Force meets in South Dakota (03/23)
Eastern Cherokees takes aim at substance abuse and treatment (03/23)
Senate approves comprehensive drug addiction and recovery bill (03/11)
Oneida Nation addresses increase in opiate abuse in community (03/02)
BIA and IHS announce partnership to address drug overdoses (02/18)
Spirit Lake Nation declares state of emergency to fight drugs (08/31)
Gyasi Ross: Indian Country entering a new era with drug game (08/19)
White House heroin plan includes tribes devastated by drug (08/18)
Senate committee examines costs of substance abuse on tribes (7/30)